Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 2,567 | 2,511 | 3,076 | 2,171 | 665 |
| Gross Profit | 2,567 | 2,511 | 3,076 | 2,171 | 665 |
| Operating Expenses | 26,425 | 39,563 | 41,729 | 38,421 | 37,377 |
| Operating Income | -23,858 | -37,052 | -38,653 | -36,250 | -36,712 |
| Interest Expense | 702 | 699 | 689 | 679 | 784 |
| Other Income | 1,583 | 2,041 | 2,390 | 2,802 | 1,687 |
| Pre-tax Income | -22,977 | -35,710 | -36,952 | -34,127 | -35,809 |
| Net Income Continuous | -22,977 | -35,710 | -36,952 | -34,127 | -35,809 |
| Net Income | $-22,977 | $-35,710 | $-36,952 | $-34,127 | $-35,809 |
| EPS Basic Total Ops | -0.18 | -0.28 | -0.28 | -0.26 | -0.29 |
| EPS Basic Continuous Ops | -0.18 | -0.28 | -0.28 | -0.26 | -0.29 |
| EPS Diluted Total Ops | -0.18 | -0.28 | -0.28 | -0.26 | -0.29 |
| EPS Diluted Continuous Ops | -0.18 | -0.28 | -0.28 | -0.26 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.28 | -0.28 | -0.26 | -0.29 |
| EBITDA(a) | $-23,135 | $-36,285 | $-37,955 | $-35,572 | $-36,001 |